Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study

Zhi-Zhao Li; Xin Du; Nian Liu; Xue-yuan Guo; Chao Jiang; Liu He; Shi-jun Xia; Wei Wang; Ri-bo Tang; San-shuai Chang; Rong-hui Yu; De-yong Long; Rong Bai; Cai-hua Sang; Song-nan Li; Jian-zeng Dong; Chang-sheng Ma

doi:10.12659/MSM.934747

14 April 2022: Database Analysis

Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study

Zhi-Zhao Li ^12ABCDEF , Xin Du ^2A , Nian Liu ^2A , Xue-yuan Guo ^2A , Chao Jiang ^2A , Liu He ^2C , Shi-jun Xia ^2A , Wei Wang ^2A , Ri-bo Tang ^2A , San-shuai Chang ^2A , Rong-hui Yu ^2A , De-yong Long ^2A , Rong Bai ^2A , Cai-hua Sang ^2A , Song-nan Li ^2A , Jian-zeng Dong ^2A , Chang-sheng Ma ^2A*

DOI: 10.12659/MSM.934747

Med Sci Monit 2022; 28:e934747

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 2 (A) Stroke/thromboembolism and cardiovascular mortality-free survival rate by quartile of LDL-C with CHA2DS2-VASc score <2. (B) Stroke/thromboembolism and cardiovascular mortality-free survival rate by quartile of LDL-C with CHA2DS2-VASc score ≥2.

Back to the Article

Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study

Your Privacy